{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:02:24Z","timestamp":1793613744672,"version":"4.5.0"},"reference-count":73,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:p>Cystic fibrosis (CF) is one of the most commonly diagnosed genetic disorders. Clinical characteristics include progressive obstructive lung disease, sinusitis, exocrine pancreatic insufficiency leading to malabsorption and malnutrition, liver and pancreatic dysfunction, and male infertility. Although CF is a life-shortening disease, survival has continued to improve to a median age of 46.2 years due to earlier diagnosis through routine newborn screening, promulgation of evidence-based guidelines to optimize nutritional and pulmonary health, and the development of CF-specific interdisciplinary care centers. Future improvements in health and quality of life for individuals with CF are likely with the recent development of mutation-specific modulator therapies. In this review, we will cover the current understanding of the disease manifestations, diagnosis, and management as well as common complications seen in individuals with CF.<\/jats:p>","DOI":"10.1542\/pir.2019-0212","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T05:21:10Z","timestamp":1612156870000},"page":"55-67","source":"Crossref","is-referenced-by-count":127,"title":["Cystic Fibrosis"],"prefix":"10.1542","volume":"42","author":[{"given":"Kimberly M.","family":"Dickinson","sequence":"first","affiliation":[{"name":"Eudowood Division of Pediatric Respiratory Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Collaco","sequence":"additional","affiliation":[{"name":"Eudowood Division of Pediatric Respiratory Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"issue":"2","key":"2022032113453884100_B1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"Cystic fibrosis of the pancreas and its relation to celiac disease","volume":"56","author":"Andersen","year":"1938","journal-title":"Am J Dis Child"},{"key":"2022032113453884100_B2","volume-title":"Annual Data Report.","author":"Cystic Fibrosis Foundation Patient Registry","year":"2019"},{"issue":"2","key":"2022032113453884100_B3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3476(98)70441-X","article-title":"Comparison of the clinical manifestations of cystic fibrosis in black and white patients","volume":"132","author":"Hamosh","year":"1998","journal-title":"J Pediatr"},{"issue":"6","key":"2022032113453884100_B4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1373\/clinchem.2010.159285","article-title":"Cystic fibrosis carrier testing in an ethnically diverse US population","volume":"57","author":"Rohlfs","year":"2011","journal-title":"Clin Chem"},{"key":"2022032113453884100_B5","unstructured":"Cystic Fibrosis Foundation. Carrier testing for cystic fibrosis. Available at: https:\/\/www.cff.org\/What-is-CF\/Testing\/Carrier-Testing-for-Cystic-Fibrosis\/. Accessed August 1, 2019"},{"key":"2022032113453884100_B6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1172-7-14","article-title":"Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France","volume":"7","author":"Scotet","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2022032113453884100_B7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOP.0b013e328353489a","article-title":"Newborn screening for cystic fibrosis","volume":"24","author":"Wagener","year":"2012","journal-title":"Curr Opin Pediatr"},{"issue":"5","key":"2022032113453884100_B8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1542\/peds.12.5.549","article-title":"Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease","volume":"12","author":"Di Sant\u2019Agnese","year":"1953","journal-title":"Pediatrics"},{"issue":"3","key":"2022032113453884100_B9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1542\/peds.23.3.545","article-title":"A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis","volume":"23","author":"Gibson","year":"1959","journal-title":"Pediatrics"},{"key":"2022032113453884100_B10","unstructured":"The Clinical and Functional TRanslation of CFTR. Available at: http:\/\/cftr2.org\/. Accessed July 31, 2019"},{"key":"2022032113453884100_B11","unstructured":"Dorfman\u2008R\n          , for the CFMD\/CFTR1 Team. Cystic fibrosis mutation database. Available at: http:\/\/www.genet.sickkids.on.ca\/cftr\/app. Accessed July 17, 2019"},{"issue":"9","key":"2022032113453884100_B12","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1164\/rccm.201901-0145OC","article-title":"Correlating cystic fibrosis transmembrane conductance regulator function with clinical features to inform precision treatment of cystic fibrosis","volume":"199","author":"McCague","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"5-6","key":"2022032113453884100_B13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/BF01076961","article-title":"Prenatal diagnosis of the fetus with cystic fibrosis and meconium ileus","volume":"12","author":"Irish","year":"1997","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"2022032113453884100_B14","first-page":"9","article-title":"Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome?","volume":"5","author":"De Oronzo","year":"2011","journal-title":"J Prenat Med"},{"issue":"2","key":"2022032113453884100_B15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0037-1609025","article-title":"Pediatric rectal prolapse","volume":"31","author":"Rentea","year":"2018","journal-title":"Clin Colon Rectal Surg"},{"issue":"5","key":"2022032113453884100_B16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1542\/pir.35.5.194","article-title":"Cystic fibrosis","volume":"35","author":"Paranjape","year":"2014","journal-title":"Pediatr Rev"},{"issue":"1","key":"2022032113453884100_B17","first-page":"43","article-title":"Gastrointestinal manifestations of cystic fibrosis","volume":"12","author":"Sabharwal","year":"2016","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"1","key":"2022032113453884100_B18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1542\/peds.55.1.86","article-title":"Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes","volume":"55","author":"Shwachman","year":"1975","journal-title":"Pediatrics"},{"issue":"10","key":"2022032113453884100_B19","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/humrep\/deh405","article-title":"Fertility and pregnancy outcomes in men and women with cystic fibrosis in the United Kingdom","volume":"19","author":"Boyd","year":"2004","journal-title":"Hum Reprod"},{"issue":"6)(","key":"2022032113453884100_B20","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Borowitz","year":"2009","journal-title":"J Pediatr"},{"issue":"1","key":"2022032113453884100_B21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ppul.1950060111","article-title":"Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test","volume":"6","author":"Rock","year":"1989","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"2022032113453884100_B22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpeds.2008.04.061","article-title":"Newborn screening for cystic fibrosis: a lesson in public health disparities","volume":"153","author":"Ross","year":"2008","journal-title":"J Pediatr"},{"issue":"1","key":"2022032113453884100_B23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0925-6164(93)90013-9","article-title":"Immunoreactive trypsinogen levels in infants with cystic fibrosis complicated by meconium ileus","volume":"2","author":"Rusakow","year":"1993","journal-title":"Screening"},{"key":"2022032113453884100_B24","article-title":"Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"issue":"2","key":"2022032113453884100_B25","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J Pediatr"},{"issue":"4","key":"2022032113453884100_B26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/adc.48.4.316","article-title":"Sweat tests in the newborn period","volume":"48","author":"Hardy","year":"1973","journal-title":"Arch Dis Child"},{"issue":"5","key":"2022032113453884100_B27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.GIM.0000139505.06194.39","article-title":"Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population","volume":"6","author":"Palomaki","year":"2004","journal-title":"Genet Med"},{"issue":"4","key":"2022032113453884100_B28","first-page":"135","article-title":"The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era","volume":"26","author":"Mishra","year":"2005","journal-title":"Clin Biochem Rev"},{"key":"2022032113453884100_B29","doi-asserted-by":"crossref","first-page":"e20151784","DOI":"10.1542\/peds.2015-1784","article-title":"Clinical practice guidelines from the Cystic Fibrosis Foundation for preschoolers with cystic fibrosis","author":"Lahiri","year":"2016","journal-title":"Pediatrics"},{"issue":"7","key":"2022032113453884100_B30","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2022032113453884100_B31","first-page":"522","article-title":"Cystic fibrosis pulmonary guidelines: airway clearance therapies","volume":"54","author":"Flume","year":"2009","journal-title":"Respir Care"},{"issue":"11","key":"2022032113453884100_B32","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","article-title":"Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life","volume":"183","author":"Cohen-Cymberknoh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"2022032113453884100_B33","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","article-title":"Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection","volume":"11","author":"Mogayzel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2022032113453884100_B34","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2022032113453884100_B35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcf.2005.05.010","article-title":"Anti-inflammatory therapy in cystic fibrosis","volume":"4","author":"Dinwiddie","year":"2005","journal-title":"J Cyst Fibros"},{"issue":"4","key":"2022032113453884100_B36","first-page":"CD001505","article-title":"Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis","volume":"4","author":"Lands","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2022032113453884100_B37","first-page":"CD002203","article-title":"Macrolide antibiotics for cystic fibrosis","author":"Southern","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2022032113453884100_B38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2022032113453884100_B39","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J Am Diet Assoc"},{"issue":"6","key":"2022032113453884100_B40","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jcf.2016.08.004","article-title":"Enteral tube feeding for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed guidelines","volume":"15","author":"Schwarzenberg","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"5","key":"2022032113453884100_B41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0022-3476(95)70153-2","article-title":"Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy","volume":"127","author":"Borowitz","year":"1995","journal-title":"J Pediatr"},{"issue":"2","key":"2022032113453884100_B42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-3468(97)90186-X","article-title":"Fibrosing colonopathy in children with cystic fibrosis","volume":"32","author":"Reichard","year":"1997","journal-title":"J Pediatr Surg"},{"issue":"6","key":"2022032113453884100_B43","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00063198-200211000-00010","article-title":"Proper usage of pancreatic enzymes","volume":"8","author":"Schibli","year":"2002","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"2022032113453884100_B44","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/jc.2011-3050","article-title":"An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation","volume":"97","author":"Tangpricha","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"2022032113453884100_B45","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMe1712335","article-title":"CFTR modulator therapy for cystic fibrosis","volume":"377","author":"Grasemann","year":"2017","journal-title":"N Engl J Med"},{"issue":"19","key":"2022032113453884100_B46","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"2022032113453884100_B47","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2022032113453884100_B48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1164\/rccm.201002-0157OC","article-title":"Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax","volume":"182","author":"Flume","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"6)(pt 1","key":"2022032113453884100_B49","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1164\/ajrccm.157.6.9708067","article-title":"Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis","volume":"157","author":"Brinson","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2022032113453884100_B50","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1378\/chest.128.2.720","article-title":"Pneumothorax in cystic fibrosis","volume":"128","author":"Flume","year":"2005","journal-title":"Chest"},{"issue":"5","key":"2022032113453884100_B51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2500\/ajra.2013.27.3919","article-title":"Cystic fibrosis chronic rhinosinusitis: a comprehensive review","volume":"27","author":"Chaaban","year":"2013","journal-title":"Am J Rhinol Allergy"},{"issue":"2","key":"2022032113453884100_B52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11882-012-0250-y","article-title":"Pathogenesis and management of nasal polyposis in cystic fibrosis","volume":"12","author":"Mainz","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"2022032113453884100_B53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/0194599817739284","article-title":"Improved lung function after sinus surgery in cystic fibrosis patients with moderate obstruction","volume":"158","author":"Khalfoun","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"2022032113453884100_B54","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archoto.2011.68","article-title":"Effect of endoscopic sinus surgery on pulmonary function and microbial pathogens in a pediatric population with cystic fibrosis","volume":"137","author":"Osborn","year":"2011","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2022032113453884100_B55","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1569-1993(11)60005-2","article-title":"Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients","volume":"10","author":"Colombo","year":"2011","journal-title":"J Cyst Fibros"},{"key":"2022032113453884100_B56","volume-title":"Murray & Nadel\u2019s Textbook of Respiratory Medicine","author":"Rowe","year":"2016","edition":"6th ed."},{"issue":"4","key":"2022032113453884100_B57","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2013.02.008","article-title":"Update on cystic fibrosis-related diabetes","volume":"12","author":"Kelly","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"9","key":"2022032113453884100_B58","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"5","key":"2022032113453884100_B59","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpeds.2004.12.039","article-title":"Epidemiology of cystic fibrosis-related diabetes","volume":"146","author":"Marshall","year":"2005","journal-title":"J Pediatr"},{"issue":"12","key":"2022032113453884100_B60","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"7006","key":"2022032113453884100_B61","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.311.7006.655","article-title":"Glucose tolerance in patients with cystic fibrosis: five year prospective study","volume":"311","author":"Lanng","year":"1995","journal-title":"BMJ"},{"issue":"6","key":"2022032113453884100_B62","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"2022032113453884100_B63","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J Cyst Fibros"},{"key":"2022032113453884100_B64","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005176-199900001-00001","article-title":"Recommendations for management of liver and biliary tract disease in cystic fibrosis","volume":"28","author":"Sokol","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"2022032113453884100_B65","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.2009.1295","article-title":"Genetic modifiers of liver disease in cystic fibrosis","volume":"302","author":"Bartlett","year":"2009","journal-title":"JAMA"},{"issue":"6","key":"2022032113453884100_B66","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MCP.0000000000000428","article-title":"Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease","volume":"23","author":"van de Peppel","year":"2017","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"2022032113453884100_B67","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2022032113453884100_B68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","article-title":"International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety","volume":"71","author":"Quittner","year":"2016","journal-title":"Thorax"},{"issue":"4","key":"2022032113453884100_B69","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.acap.2014.03.008","article-title":"The Transition Readiness Assessment Questionnaire (TRAQ): its factor structure, reliability, and validity","volume":"14","author":"Wood","year":"2014","journal-title":"Acad Pediatr"},{"issue":"5","key":"2022032113453884100_B70","doi-asserted-by":"crossref","first-page":"e1160","DOI":"10.1542\/peds.2007-2217","article-title":"Improving transition from pediatric to adult cystic fibrosis care: lessons from a national survey of current practices","volume":"121","author":"McLaughlin","year":"2008","journal-title":"Pediatrics"},{"issue":"12","key":"2022032113453884100_B71","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/rccm.201303-0429OC","article-title":"Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation","volume":"187","author":"Thabut","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"2022032113453884100_B72","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.healun.2018.07.020","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult lung and heart-lung transplant report-2018: focus theme: multiorgan transplantation","volume":"37","author":"Chambers","year":"2018","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"2022032113453884100_B73","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J Cyst Fibros"}],"container-title":["Pediatrics In Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/42\/2\/55\/1270311\/pedsinreview_20190212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/42\/2\/55\/1270311\/pedsinreview_20190212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T09:47:04Z","timestamp":1647856024000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article\/42\/2\/55\/35475\/Cystic-Fibrosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":73,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,1]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/pir.2019-0212","relation":{},"ISSN":["0191-9601","1526-3347"],"issn-type":[{"value":"0191-9601","type":"print"},{"value":"1526-3347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}